Showing 2521-2530 of 23150 results for "".
Unmet Need: Second-Line Outcomes Remain Poor for NSCLC and Pancreatic Cancer
https://reachmd.com/programs/cme/unmet-need-second-line-outcomes-remain-poor-for-nsclc-and-pancreatic-cancer/54118/Explore ON-state RAS inhibitors for the treatment of NSCLC and pancreatic cancer, including mechanisms, efficacy data, and integration into clinical practice.Mechanistic Evolution in RAS Therapy: ON-State and Multi-Selective Targeting
https://reachmd.com/programs/cme/mechanistic-evolution-in-ras-therapy-on-state-and-multi-selective-targeting/54120/Explore ON-state RAS inhibitors for the treatment of NSCLC and pancreatic cancer, including mechanisms, efficacy data, and integration into clinical practice.FSGS 360°: From Patient Experience to Precision Medicine
https://reachmd.com/programs/cme/fsgs-360-from-patient-experience-to-precision-medicine/35905/FSGS 360°: From Patient Experience to Precision MedicineEvaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors
https://reachmd.com/programs/cme/evaluating-use-in-pancreatic-cancer-efficacy-and-safety-data-for-on-state-ras-inhibitors/54122/Explore ON-state RAS inhibitors for the treatment of NSCLC and pancreatic cancer, including mechanisms, efficacy data, and integration into clinical practice.NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
https://reachmd.com/programs/cme/nsclc-data-review-efficacy-and-safety-data-for-on-state-ras-inhibitors/54121/Explore ON-state RAS inhibitors for the treatment of NSCLC and pancreatic cancer, including mechanisms, efficacy data, and integration into clinical practice.RAS(ON) and Beyond: Clinical Integration and Strategic Sequencing
https://reachmd.com/programs/cme/rason-and-beyond-clinical-integration-and-strategic-sequencing/54124/Explore ON-state RAS inhibitors for the treatment of NSCLC and pancreatic cancer, including mechanisms, efficacy data, and integration into clinical practice.Study Finds Survival After Cardiac Arrest Improves When More Patients Receive Bystander CPR and External Defibrillation
https://reachmd.com/programs/the-jama-report/study-finds-survival-after-cardiac-arrest-improves-when-more-patients-receive-bystander-cpr/7637/[Read the Article] Out-of-hospital cardiac arrest is a major public health issue, accounting for approximately 200,000 deaths per year in the United States. A new study examined whether increased use of defibrillators and cardiopulmonary resuscitation (CPR) by first responders and bystanders could hGenerating More Than Buzz
https://reachmd.com/topics/practice-development/generating-more-than-buzz/35419/Pioneers in the field share key information at Genesis: Innovations in Aesthetic Regenerative MedicineBreaking the Cycle: Prioritizing Weight Loss to Improve OSA Management
https://reachmd.com/programs/cme/breaking-the-cycle-prioritizing-weight-loss-to-improve-osa-management/48715/On-demand webcast of expert faculty presentation on the connection between obstructive sleep apnea (OSA) and obesity, including strategies for prioritizing weight loss to improve OSA management among select patients.Logistical Considerations with Anti-VEGF Treatment in Wet AMD
https://reachmd.com/programs/eye-on-ocular-health/logistical-considerations-anti-vegf-wet-amd/56544/